Tower Research Capital (TRC)’s Sionna Therapeutics SION Stock Holding History
Bought
Maintained
Sold
Other funds holding SION
Tower Research Capital (TRC)'s SION Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Sionna Therapeutics (SION) stake by 1,940% in Q3 2026, buying an estimated $570K and bringing the position to 26,094 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2614.
Tower Research Capital (TRC) first reported a position in SION in Q3 2025 and has held it in 5 quarters since. 134 funds tracked by Wall St. Rank hold SION as of Q3 2026.
- Tower Research Capital (TRC) held 26,094 shares of Sionna Therapeutics worth $137K as of Q3 2026.
- Tower Research Capital (TRC) bought 24,815 Sionna Therapeutics shares in Q3 2026, an estimated $570K.
- Sionna Therapeutics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #2614 holding.
- Tower Research Capital (TRC) first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 134 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.